These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 3906398

  • 1. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y.
    N Engl J Med; 1985 Dec 26; 313(26):1617-20. PubMed ID: 3906398
    [Abstract] [Full Text] [Related]

  • 2. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J, Banihashemi MA, Ghezlou M, Afshariani R, Salari S, Moini M, Sagheb MM.
    Ren Fail; 2010 Jan 26; 32(2):172-8. PubMed ID: 20199178
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP, Raskovic M, Schimke E.
    Dtsch Med Wochenschr; 1994 Jun 03; 119(22):796-800. PubMed ID: 8205941
    [Abstract] [Full Text] [Related]

  • 5. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
    Komers R, Malý J, Simková R.
    Cas Lek Cesk; 1993 Jun 14; 132(12):359-64. PubMed ID: 8343943
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
    Matsubara M, Taguma Y, Saito T, Yoshinaga K.
    Nihon Jinzo Gakkai Shi; 1992 Apr 14; 34(4):411-6. PubMed ID: 1635286
    [Abstract] [Full Text] [Related]

  • 8. [Effect of the ACE-inhibitor captopril on the blood pressure and kidney function of patients with essential and renal hypertension].
    Jansa U, Stein G, Günther K.
    Z Gesamte Inn Med; 1991 Dec 14; 46(17):642-7. PubMed ID: 1776307
    [Abstract] [Full Text] [Related]

  • 9. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
    Lewis EJ, Hunsicker LG, Bain RP, Rohde RD.
    N Engl J Med; 1993 Nov 11; 329(20):1456-62. PubMed ID: 8413456
    [Abstract] [Full Text] [Related]

  • 10. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Nov 11; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 11. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.
    Tajiri Y, Umeda F, Inoguchi T, Kunisaki M, Nawata H, Ninomiya H, Asano T.
    Diabetes Res; 1990 Mar 11; 13(3):145-50. PubMed ID: 2091882
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of antihypertensive (captopril) therapy on proteinuria in diabetic nephropathy].
    Holländer E.
    Orv Hetil; 1987 Apr 26; 128(17):893-5. PubMed ID: 3295665
    [No Abstract] [Full Text] [Related]

  • 14. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
    Masunaga Y, Tabei K, Takeda S, Ando Y, Kusano E, Asano Y.
    Nihon Jinzo Gakkai Shi; 1993 Aug 26; 35(8):961-6. PubMed ID: 8255007
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
    Aminorroaya A, Janghorbani M, Rezvanian H, Aminian T, Gharavi M, Amini M.
    Nephron Clin Pract; 2005 Aug 26; 99(3):c73-7. PubMed ID: 15665549
    [Abstract] [Full Text] [Related]

  • 16. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H, Hayashi K, Saruta T.
    J Hum Hypertens; 2003 Apr 26; 17(4):271-6. PubMed ID: 12692572
    [Abstract] [Full Text] [Related]

  • 17. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.
    Clin Exp Nephrol; 2003 Sep 26; 7(3):221-30. PubMed ID: 14586719
    [Abstract] [Full Text] [Related]

  • 18. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM, Tareeva IE, Shestakova MV, Gerasimenko OI, Zverev KV, Rogov VA, Sheremet'eva OV.
    Ter Arkh; 1994 Sep 26; 66(6):19-22. PubMed ID: 7940357
    [Abstract] [Full Text] [Related]

  • 19. Effect of captopril on heavy proteinuria in patients with various glomerular diseases.
    Han DS, Ha SK, Choi KH, Lee HY.
    Yonsei Med J; 1992 Sep 26; 33(3):232-9. PubMed ID: 1292247
    [Abstract] [Full Text] [Related]

  • 20. [Effect of ACE inhibitors on proteinuria and renal functioning in primary glomerulopathies].
    Boratyńska M, Mazanowska O, Szewczyk Z, Czyz W.
    Pol Tyg Lek; 1992 Sep 26; 47(49-50):1090-2. PubMed ID: 1305732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.